The Influence of Immunology and Genetics on Lymphoma Classification: A Historical Perspective

References

• Falzon M, Issacson P G. Histological classification of the non-Hodgkin's lymphoma. Blood Rev 1990; 4: 111–115
   PubMed Web of Science ®Google Scholar
• Maim R B, Jaffe E S, Berard C W. Malignant lymphomas—A conceptual understanding of morphologic diversity: A review. Am J Pathol 1979; 94(1)105–176
   PubMedGoogle Scholar
• Rappaport H. Tumors of the hematopoietic system. Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC 1966; 9–14, Section 3, Fascicle 8
   Google Scholar
• Nathwani B N. A critical analysis of the classifications of non-Hodgkin's lymphomas. Cancer 1979; 44: 347–384
   PubMed Web of Science ®Google Scholar
• Isaacson P G. Recent advances in the biology of lymphomas. Eur J Cancer 1991; 27: 795–802
   PubMed Web of Science ®Google Scholar
• Aisenberg A C. Current concepts in immunology: Cell surface markers in lymphoproliferative disease. N Engl J Med 1981; 304: 331–336
   PubMed Web of Science ®Google Scholar
• Hansen J A, Good R A. Malignant disease of the lymphoid system in immunological perspective. Hum Pathol 1974; 5(5)567–599
   PubMed Web of Science ®Google Scholar
• Stein H, Lennert K, Feller A C, Mason D Y. Immunohistological analysis of human lymphoma: Correlation of histological and immunological categories. Adv Cancer Res 1984; 42: 67–147
   PubMed Web of Science ®Google Scholar
• Lukes R J, Taylor C R, Chir B, et al. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol 1978; 90: 461–480
   PubMed Web of Science ®Google Scholar
• Collins R D, Lukes R J. Studies on possible derivation of some malignant lymphomas from follicular center cells. Am J Pathol 1971; 62: 63a, abstract
   Web of Science ®Google Scholar
• Lukes R J, Parker J W, Taylor C R, et al. Immunologic approach to non-Hodgkin lymphomas and related leukemias: Analysis of the results of multiparameter studies of 425 cases. Semin Hematol 1978; 15: 322–351
   PubMed Web of Science ®Google Scholar
• Dorfman R F. Classification of non-Hodgkin's lymphomas. Lancet 1974; 1: 1295–1296
   PubMed Web of Science ®Google Scholar
• Bennett M H, Farrer-Brown G, Henry K, et al. Classification of non-Hodgkin's lymphomas. Lancet 1974; 2: 405–406
   Web of Science ®Google Scholar
• Mathe G, Rappaport H, O'Conor G T, Torlini H. Histological and cytological typing of neoplastic diseases of hematopoietic and lymphoid tissues. WHO International Histological Classification of Tumors. World Health Organization, Geneva 1976, No. 14
   Google Scholar
• Higby D J. A practical classification of lymphomas. N Engl J Med 1979; 300(12)283
   Google Scholar
• Parker J W. Immunologic basis for the redefinition of malignant lymphomas. Am J Clin Pathol 1979; 72(4)670–686
   PubMed Web of Science ®Google Scholar
• Taylor C R, Chir B, Phil D. Classification of lymphoma: New thinking onold thoughts. Arch Pathol Lab Med 1978; 102: 549–554
   PubMed Web of Science ®Google Scholar
• Nathwani B N, Hun K, Rappaport H, et al. Non-Hodgkin's lymphomas: A clinicopathologic study comparing two classifications. Cancer 1978; 41: 303–325
   PubMed Web of Science ®Google Scholar
• National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage: The non-Hodgkin's lymphoma pathologic classification project. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Tubbs R R, Sheibani K, Weiss R A, Sebek B A. Immunohistochemistry of fresh frozen lymphoid tissue with the direct immunoperoxidase technic. Am J Clin Pathol 1981; 75: 172–174
   PubMed Web of Science ®Google Scholar
• Hoffman-Fezer G, Rodt H, Eulitz M, et al. Immunohistochemical identification of T and B lymphocytes delineated by the unlabeled antibody enzyme method. I. Anatomical distribution of theta+ and Ig+cells in lymphoid organs of mice. J Immunol Meth 1976; 13: 261–270
   PubMed Web of Science ®Google Scholar
• Warlike R, Levy R. Immunopathology of follicular lymphomas: A model of B-lymphocytehoming. N Engl J Med 1978; 298: 481–486
   PubMed Web of Science ®Google Scholar
• Tubbs R, Sheibani K, Sebek B, Weiss R. Immunohistochemistry vs immunofluorescence for non-Hodgkin's lymphomas. Am J Clin Pathol 1980; 73: 144, letter
   PubMed Web of Science ®Google Scholar
• Tubbs R R, Sheibani K, Weiss R A, et al. Tissue immunomicroscopic evaluation of monoclonality of B cell lymphomas: Comparison with cell suspension studies. Am J Clin Pathol 1981; 76: 24–28
   PubMed Web of Science ®Google Scholar
• Tubbs R R, Sheibani K, Deodhar S D. Enzyme immunohistochemistry: Review of technical aspects and diagnostic applications. Cleve Clin Q 1981; 48(2)245–281
   PubMedGoogle Scholar
• Tubbs R R, Fishleder A, Weiss R A, et al. Immunohistologic study of lymphoproliferative disorders: Evaluation of 564 cases, including 267 classified by the International Working Formulation. Am J Pathol 1983; 113: 207–221
   PubMed Web of Science ®Google Scholar
• Sheibani K, Tubbs R R. Enzyme immunohistochemistry: Technical aspects. Semin Diagn Pathol 1984; 1: 235–250
   PubMedGoogle Scholar
• Warnke R, Pederson M, Willliams C, Levy R. A study of lymphoproliferative diseases comparing immunofluorescence with immunohistochemistry. Am J Clin Pathol 1978; 70: 867–875
   Web of Science ®Google Scholar
• Grogan T M, Tubbs R R. A double-blind comparative immunotypic study between two institutions phenotyping non-Hodgkin's lymphomas. Am J Clin Pathol 1987; 87: 478–484
   PubMed Web of Science ®Google Scholar
• Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–497
   PubMed Web of Science ®Google Scholar
• Hsu S M, Raine L, Fanger H. A comparative study of the PAP method and avidin-biotin-complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981; 75: 734–738
   PubMed Web of Science ®Google Scholar
• Keller R H, Milson T J, Janicek K M, Patrick C W. Monoclonal antibodies: Clinical utility and the misunderstoodepitope. Lab Med 1984; 15(12)795–801
   Google Scholar
• Knowles D M. Immunophenotypic and immunogenotypic approaches useful in distinguishing benign and malignant lymphoid proliferations. Semin Oncol 1993; 29(6)583–610
   Google Scholar
• Tubbs R R, Sheibani K. Immunohistology of lymphoproliferative disorders. Semin Diagn Pathol 1984; 1: 272–284
   PubMedGoogle Scholar
• Picker L J, Weiss L M, Medeiros L J, et al. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 1987; 128: 181–201
   PubMed Web of Science ®Google Scholar
• Grogan T M, Miller T P. New biologic markers in non-Hodgkin's lymphomas. Hematol Oncol Clin North Am 1991; 5(5)925–933
   PubMed Web of Science ®Google Scholar
• Grogan T M, Lippman S M, Spier C M, et al. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood 1988; 71(4)1157–1160
   PubMed Web of Science ®Google Scholar
• Miller T P, Grogan T M, Dahlberg S, et al. Prognostic significance of the Ki-67 associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group trial. Blood 1994; 83(6)1460–1466
   PubMed Web of Science ®Google Scholar
• Segal G, Stoler M, Fishleder A, Tubbs R. Reliable and cost-effective paraffin section immunohistology of lymphoproliferative disorders. Am J Surg Pathol 1991; 15: 1034–1041
   PubMed Web of Science ®Google Scholar
• Gelb A B, Rouse R V, Dorfman R F, Warnke R A. Detection of immunophenotypic abnormalities in paraffin-embedded B-lineage non-Hodgkin's lymphomas. Am J Clin Pathol 1994; 102: 825–834
   PubMed Web of Science ®Google Scholar
• Parker J W. Flow cytometric analysis of lymphoproliferative disorders using monoclonal antibodies. Lab Med 1985; 16(1)21–31
   Google Scholar
• Patrick C W, Milson T J, McFadden P W, Keller R H. Flow cytometry and cell sorting. Lab Med 1984; 15(11)740–745
   Google Scholar
• Parker J W. Flow cytometry in the diagnosis in hematologic diseases. Ann Clin Lab Sci 1986; 16(6)427–442
   PubMed Web of Science ®Google Scholar
• Parks D R, Hardy R R, Herzenberg L A. Dual immunofluorescence—New frontiers in cell analysis and sorting. Immunol Today 1983; 4(5)145–150
   PubMedGoogle Scholar
• Braylan R C, Benson N A. Flow cytometric analysis of lymphomas. Arch Pathol Lab Med 1989; 113: 627–633
   PubMed Web of Science ®Google Scholar
• Segal G H, Edinger M, Owen M, et al. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three color immunocytometry. Cytometry 1991; 12: 350–359
   PubMedGoogle Scholar
• Diaz J, Edinger M, Stoler M, Tubbs R. Host tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. Leukemia Lymphoma 1993; 9: 85–90
   PubMed Web of Science ®Google Scholar
• Diaz J, Tubbs R, Stoler M, et al. Cytolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. Leukemia Lymphoma 1993; 9: 85–90
   PubMed Web of Science ®Google Scholar
• Witzig T E, Banks P M, Stenson M J, et al. Rapid immunolyping of B-cell non-Hodgkin's lymphomas by flow cytometry: A comparison with the standard frozen section method. Am J Clin Pathol 1990; 94: 280–286
   PubMed Web of Science ®Google Scholar
• Borst J, Brouns G S, DeVries E, et al. Antigen receptors on T and B lymphocytes: Parallels in organization and function. Immunol Rev 1993; 132: 49–84
   PubMed Web of Science ®Google Scholar
• Seemayer T A, Cavenee W K. Biology of disease: Molecular mechanisms of oncogcnesis. Lab Invest 1989; 60(5)585–599
   PubMed Web of Science ®Google Scholar
• Cossman J, Uppenkamp M, Sundeen J, et al. Molecular genetics and the diagnosis of lymphoma. Arch Pathol Lab Med 1988; 112: 117–127
   PubMed Web of Science ®Google Scholar
• Katzin W E, Linden M D, Fishleder A J, Tubbs R R. Immunophenotypic and genotypic characterization of diffuse mixed non-Hodgkm's lymphomas. Am J Pathol 1989; 135: 615–621
   PubMed Web of Science ®Google Scholar
• Medeiros L J, Bagg A, Cossman J. Molecular genetics in the diagnosis and classification of lymphoid neoplasias. Surgical Pathology of the Lymph Nodes and Related Organs, Major Problems in Pathology, 2nd ed. WB Saunders, Philadelphia 1995; Vol 16: 48–97
   Google Scholar
• Magrath I, Barriga F, McManaway M, Shiramizu B. The molecular analysis of chromosomal translocations as a diagnostic, epidemiological and potentially prognostic tool in lymphoid neoplasia. J Virol Meth 1988; 21: 275–289
   PubMed Web of Science ®Google Scholar
• Sklar J L, Weiss L M, Cleary M L. Diagnostic molecular biology of non-Hodgkin's lymphomas. Monogr Pathol 1987; 29: 204–224
   PubMedGoogle Scholar
• Segal G, Wittwer C, Fishleder A, et al. Identification of monoclonal B cell populations by rapid cycle polymerase chain reaction: A practical screening method for the detection of immunoglobulin gene rearrangements. Am J Pathol 1992; 141: 1291–1297
   PubMed Web of Science ®Google Scholar
• Segal G H, Jorgensen T, Scott M. Optimal primer selection for clonality assessment by polymerase chain reaction analysis. II. Follicular lymphomas. Hum Pathol 1994; 25: 1276–1282
   PubMed Web of Science ®Google Scholar
• Segal G H, Jorgensen T, Masih A S, et al. Optimal primer selection for clonality assessment by polymerase chain reaction analysis. 1. Low grade B cell lymphoproliferative disorders of nonfollicular center cell type. Hum Pathol 1994; 25: 1269–1275
   PubMed Web of Science ®Google Scholar
• Segal G H, Shick H E, Tubbs R R, et al. In situ hybridization analysis of lymphoproliferative disorders: Assessment of clonality of immunoglobulin light chain messenger RNA expression. Diagn Mol Pathol 1994; 3(3)170–177
   PubMed Web of Science ®Google Scholar
• Grody W W, Cheng L, Lewin K J. Application of in situ DNA hybridization technology to diagnostic surgical pathology. Pathol Ann 1987; 22(Pt 2)151–175
   Google Scholar
• Gaffey M J, Weiss L M. Association of Epstein-Barr virus with human neoplasia. Pathol Ann 1992; 27(Pt 1)55–74
   Google Scholar
• Anastasi J. Interphase cytogenetic analysis in the diagnosis and study of neoplastic disorders. Am J Clin Pathol 1991; 95(Suppl 1)S22–S28
   PubMedGoogle Scholar
• Harris N L. Lymphoma 1987: An interim approach to diagnosis and classification. Pathol Ann 1987; 22(Pt 2)1–67
   Google Scholar
• Harris N L, Jaffe E S, Stein H, et al. A revised European-American Classification of Lymphoid Neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84(5)1361–1392
   PubMed Web of Science ®Google Scholar
• Sander C A, Jaffe E S, Gebhardt F C, et al. Mediastinal lymphoblastic lymphomas with an immature B cell immunophenotype. Am J Surg Pathol 1992; 16(3)300–305
   PubMed Web of Science ®Google Scholar
• Buccheri V, Mihaljevic B, Matutes E, et al. mb-1: A new marker for B-lineage lymphoblastic leukemia. Blood 1993; 82(3)853–857
   PubMed Web of Science ®Google Scholar
• Cossman J, Chused T M, Fisher R I, et al. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 1983; 43: 4486–4490
   PubMed Web of Science ®Google Scholar
• Warnke R A, Link M P. Identification and significance of cell markers in leukemia and lymphoma. Annu Rev Med 1983; 34: 117–131
   PubMed Web of Science ®Google Scholar
• Flug F, Dodson L, Wolff J, et al. B-lymphocyte associated differentiation antigen expression by non-B, non-T, acute lymphoblastic leukemia. Leuk Res 1985; 9(8)1051–1058
   PubMed Web of Science ®Google Scholar
• Tubbs R R, Fishleder A, Weiss R A, et al. Immunohistologic cellular phenotypes of lymphoproliferative disorders: Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation. Am J Pathol 1983; 113: 207–221
   PubMed Web of Science ®Google Scholar
• Sundeen J T, Longo D L, Jaffe E S. CD5 expression in B cell small lymphocytic malignancies: Correlations with clinical presentation and sites of disease. Am J Surg Pathol 1992; 16(2)130–137
   PubMed Web of Science ®Google Scholar
• Harris N L, Bhan A K. B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: Immunohistologic analysis and clinical correlation. Hum Pathol 1985; 16: 829–837
   PubMed Web of Science ®Google Scholar
• Almasri N M, Duque R E, Iturraspe J, et al. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol 1992; 40: 259–263
   PubMed Web of Science ®Google Scholar
• Spier C M, Grogan T M, Fielder K, et al. Immunophenotypes in well-differentiated lymphoproliferative disorders with emphasis on small lymphocytic lymphoma. Hum Pathol 1986; 17: 1126–1136
   PubMed Web of Science ®Google Scholar
• Sheibani K, Nathwani B N, Winberg C D, et al. Small lymphocytic lymphoma: Morphologic and immunologic progression. Am J Clin Pathol 1985; 84: 237–243
   PubMed Web of Science ®Google Scholar
• Strickler J G, Medeiros J, Copenhaver C M, et al. Intermediate lymphocytic lymphoma: An immunophenotypic study with comparison to small lymphocylic lymphoma and diffuse small cleaved cell lymphoma. Hum Pathol 1988; 19: 550–554
   PubMed Web of Science ®Google Scholar
• Zukerberg L R, Medeiros J L, Ferry J A, Harris N L. Diffuse low-grade B-cell lymphomas—Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 1993; 100: 373–385
   PubMed Web of Science ®Google Scholar
• Dorfman D M, Pinkus G S. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol 1994; 7(3)326–331
   PubMed Web of Science ®Google Scholar
• Segal G, Stoler M, Tubbs R. The CD43 only phenotype: An aberrant, nonspecific immunophenotype requiring comprehensive analysis for lineage resolution. Am J Clin Pathol 1992; 97: 861–865
   PubMed Web of Science ®Google Scholar
• Fisher R I, Dahlberg S, Nathwani B N, et al. A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group Study. Blood 1995; 85(4)1075–1082
   PubMed Web of Science ®Google Scholar
• Lardelli P, Bookman M A, Sundeen J, et al. Lymphocytic lymphoma of intermediate differentiation: Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 1990; 14(8)752–763
   PubMed Web of Science ®Google Scholar
• Samoszuk M K, Epstein A L, Said J, et al. Sensitivity and specificity of immunostaining in the diagnosis of mantle zone lymphoma. Am J Clin Pathol 1986; 85: 557–563
   PubMed Web of Science ®Google Scholar
• Ellison D J, Turner R R, Antwerp R V, et al. High grade mantle zone lymphoma. Cancer 1987; 60: 2717–2720
   PubMed Web of Science ®Google Scholar
• Frizzera G, Sakurai M, Notohara K, Konishi H. t(11;14)(q13;q32) in B cell lymphomas (intermediately differentiated lymphocytic and follicular): A report of four cases. Am J Clin Pathol 1991; 95: 684–691
   PubMed Web of Science ®Google Scholar
• Bosch F, Jares P, Campo E, et al. PRAD-1/Cyclin D1 gene over-expression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma. Blood 1994; 84(8)2726–2732
   PubMed Web of Science ®Google Scholar
• Grogan T M, Hicks M J, Jolley C S, et al. Identification of two major B cell forms of nodular mixed lymphoma. Lab Invest 1984; 51(5)504–514
   PubMed Web of Science ®Google Scholar
• Weiss L M, Warnke R A. Follicular lymphoma with blastic conversion: A report of two cases with confirmation by immunoperoxidase studies on bone marrow sections. Am J Clin Pathol 1985; 83: 681–686
   PubMed Web of Science ®Google Scholar
• Gaulard P, d'Agay M F, Peuchmaur M, et al. Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol 1992; 140(5)1089–1095
   PubMed Web of Science ®Google Scholar
• Shibata D, Hu E, Weiss L M, et al. Detection of specific t(14;18) chromosomal translocations in fixed tissues. Hum Pathol 1990; 21: 199–203
   PubMed Web of Science ®Google Scholar
• Harris N L. Extranodal lymphoid infiltrates and mucosa-associated lymphoid tissue (MALT)—A unifying concept. Am J Surg Pathol 1991; 15(9)879–884
   PubMed Web of Science ®Google Scholar
• Schmid C, Kirkham N, Diss T, Isaacson P C. Splenic marginal zone cell lymphoma. Am J Surg Pathol 1992; 16(5)455–466
   PubMed Web of Science ®Google Scholar
• Ngan B Y, Warnke R A, Wilson M, et al. Monocytoid B cell lymphoma: A study of 36 cases. Hum Pathol 1991; 22: 409–421
   PubMed Web of Science ®Google Scholar
• Sheibani K, Ben-Ezra J, Swartz W G, et al. Monocytoid B-cell lymphoma in a patient with human immunodeficiency virus infection. Arch Pathol Lab Med 1990; 114: 1264–1267
   PubMed Web of Science ®Google Scholar
• Shin S S, Sheibani K. Monocytoid B-cell lymphoma. Am J Clin Pathol 1993; 99(4)421–425
   PubMed Web of Science ®Google Scholar
• Mollejo M, Menarguez J, Cristobal E, et al. Monocytoid B cells—A comparative clinical pathological study of their distribution in different types of low grade lymphomas. Am J Surg Pathol 1994; 18(11)1131–1139
   PubMed Web of Science ®Google Scholar
• Isaacson P G, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 1987; 11: 445–462
   PubMed Web of Science ®Google Scholar
• Stroup R, Sheibani K. Anligenic phenolypes of hairy cell leukenúa and monocytoid B-cell lymphoma: An immunohistochemical evaluation of 66 cases. Hum Pathol 1992; 23: 172–177
   PubMed Web of Science ®Google Scholar
• Wotherspoon A C, Diss T C, Pan L X, et al. Primary low-grade B-cell lymphoma of the conjunctiva: A mucosa-associated lymphoid tissue type lymphoma. Histopathology 1993; 23: 417–424
   PubMed Web of Science ®Google Scholar
• Melo J V, Hegde U, Parreira A, et al. Splenic B cell lymphoma with circulating villous lymphocytes: Differential diagnosis of B cell leukaemias with large spleens. J Clin Pathol 1987; 40: 642–651
   PubMed Web of Science ®Google Scholar
• Tubbs R R, Savage R A, Fishleder A, et al. Antigenic phenotype of splenic hairy cells. Am J Med 1984; 76: 199–205
   PubMed Web of Science ®Google Scholar
• Hsu S M, Yang K, Jaffe E S. Hairy cell leukemia: A B cell neoplasm with a unique antigenic phenotype. Am J Clin Pathol 1983; 80: 421–428
   PubMed Web of Science ®Google Scholar
• Miller M L, Fishleder A J, Tubbs R R. The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis. Am J Clin Pathol 1991; 96: 100–108
   PubMed Web of Science ®Google Scholar
• Falini B, Schwarting R, Erber W, et al. The differential diagnosis of hairy cell leukemia with a panel of monoclonal antibodies. Am J Clin Pathol 1985; 83: 289–300
   PubMed Web of Science ®Google Scholar
• Moller P, Mielke B, Moldenhauer G. Monoclonal antibody HML-1, a marker for intraepithelial T cells and lymphomas derived therof, also recognizes hairy cell leukemia and some B cell lymphomas. Am J Pathol 1990; 136: 509–512
   PubMed Web of Science ®Google Scholar
• Linden M D, Fishleder A J, Tubbs R R, Park H. Immunophenotypic spectrum of plasma cell leukemia. Cancer 1989; 63: 859–862
   PubMed Web of Science ®Google Scholar
• Harada H, Kawano M M, Huang N, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 1993; 81(10)2658–2663
   PubMed Web of Science ®Google Scholar
• Pellat-Deceunynck C, Bataille R, Robillard N, et al. Expression of CD28 and CD40 in human myeloma cells: A comparative study with normal plasma cells. Blood 1994; 84(8)2597–2603
   PubMed Web of Science ®Google Scholar
• Van Camp B, Durie B GM, Spier C, et al. Plasma cells in multiple myeloma express a natural killer cell-associaled antigen: CD56 (NKH-1; Leu-19). Blood 1990; 76(2)377–382
   PubMed Web of Science ®Google Scholar
• Strickler J G, Audeh M W, Copenhaver C M, Warnke R A. Immunoplienotypic differences between plasmacytoma/multiple myeloma and immunoblaslic lymphoma. Cancer 1988; 61: 1782–1786
   PubMed Web of Science ®Google Scholar
• Doggett R S, Wood G S, Horning S, et al. The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. Am J Pathol 1984; 115: 245–252
   PubMed Web of Science ®Google Scholar
• Spier C M, Grogan T M, Lippnian S M, et al. The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma. Am J Pathol 1988; 133: 118–126
   PubMed Web of Science ®Google Scholar
• Schneider D R, Taylor C R, Parker J W, et al. Immunoblastic sarcoma of T and B cell types: Morphologic description and comparison. Hum Pathol 1985; 16: 885–900
   PubMed Web of Science ®Google Scholar
• Garcia C F, Weiss L M, Warnke R A. Small noncleaved cell lymphoma: An immunophenotypic study of 18 cases and comparison with large cell lymphoma. Hum Pathol 1986; 17: 454–461
   PubMed Web of Science ®Google Scholar
• Jacobson J O, Wilkes B M, Kwiatkowski D J, et al. bcl-2 rearrangements in de novo diffuse large cell lymphoma: Association with distinctive clinical features. Cancer 1993; 72: 231–236
   PubMed Web of Science ®Google Scholar
• Lo Coco F, Ye B H, Lisla F, et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 1994; 83(7)1757–1759
   PubMed Web of Science ®Google Scholar
• Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large cell lymphoma with sclerosis: A clinicopathologic study of 60 cases. Am J Surg Pathol 1986; 10(3)176–191
   PubMed Web of Science ®Google Scholar
• Pavlova Z, Parker J W, Taylor C R, et al. Small noncleaved follicular center cell lymphoma: Burkitt's and non-Burkitt's variants in the US. II. Pathologic and immunologic features. Cancer 1987; 59, 1892–1902
   PubMed Web of Science ®Google Scholar
• Aisenberg A C. New gene tics of Burkitt's lymphoma and other non-Hodgkin's lymphomas. Am J Med 1984; 77: 1083–1089
   PubMed Web of Science ®Google Scholar
• Brownell M D, Sheibani K, Battifora H, et al. Distinction between undifferentiated (small noncleaved) and lymphoblastic lymphoma: An immunohistologic sludy on paraffin-embedded, fixed tissue sections. Am J Surg Pathol 1987; 11(10)779–787
   PubMed Web of Science ®Google Scholar
• Pelicci P G, Knowles D M, Magralh I, et al. Chromosomal break-points and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 1986; 83: 2984–2988
   PubMed Web of Science ®Google Scholar
• Neri A, Barriga F, Knowles D M, et al. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct patlhogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 1988; 85: 2748–2752
   PubMed Web of Science ®Google Scholar
• Weiss L M, Bindl J M, Picozzi V J, et al. Lymphoblastic lymphoma: An immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood 1986; 67(2)474–478
   PubMed Web of Science ®Google Scholar
• Knowles D M. The human T cell leukemias: Clinical, cylomorphologic, immunophenotypic and genotypic characteristics. Hum Pathol 1986; 17: 14–33
   PubMed Web of Science ®Google Scholar
• Riopel M, Dickman P S, Link M P, Perlman E J. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994; 25: 396–399
   PubMed Web of Science ®Google Scholar
• Stevenson A J, Chatten J, Bertoni F, et al. CD99 (p30/32mic2) Neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker: Review of more than 600 tumors and the literature experience. Appl Immunohistochem 1994; 2(4)231–240
   Google Scholar
• Cabccadas J M, Isaacson P G. Phenotyping of T cell lymphomas in paraffin sections—Which antibodies?. Histopathology 1991; 19: 419–424
   PubMed Web of Science ®Google Scholar
• Knowles D M, Pelicci P G, Datla-Favera R. T cell receptor beta chain gene rearrangements: Genetic markers of T cell lineage and clonality. Hum Pathol 1986; 17(6)546–551
   PubMed Web of Science ®Google Scholar
• Matutes E, Brito-Babapulle V, Swansbury J, et al. Clinical and laboratory featrues of 78 cases of T-prolymphocytic leukemia. Blood 1991; 78(12)3269–3274
   PubMed Web of Science ®Google Scholar
• Foa R, Pelicci P G, Migone N, et al. Analysis of T cell receptor beta chain (Tβ) gene rearrangements demonstrates the monoclonal nature of T cell chronic lymphoproliferative disorders. Blood 1986; 67(1)247–250
   PubMed Web of Science ®Google Scholar
• Suchi T, Lennert K, Tu L Y, et al. Histopathology and immunohistochemistry of peripheral T cell lymphomas: A proposal for their classification. J Clin Pathol 1987; 40: 995–1015
   PubMed Web of Science ®Google Scholar
• Loughran T P, Jr. Clonal diseases of large granular lymphocytes. Blood 1993; 82(1)1–14
   PubMed Web of Science ®Google Scholar
• Tefferi A, Li C -Y, Witzig T E, et al. Chrome natural killer cell lymphocytosis: A descriptive clinical study. Blood 1994; 84(8)2721–2725
   PubMed Web of Science ®Google Scholar
• Kwong Y L, Wong K F, Chan L C, et al. Large granular lymphocyte leukemia—A study of nine cases in a Chinese population. Am J Clin Pathol 1995; 103: 76–81
   PubMed Web of Science ®Google Scholar
• Rambaldi A, Pelicci P O, Allavena P, et al. T cell receptor β chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells. J Exp Med 1985; 162: 2156–2162
   PubMed Web of Science ®Google Scholar
• Gentile T C, Uner A H, Hutchison R E, et al. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood 1994; 84(7)2315–2321
   PubMed Web of Science ®Google Scholar
• Pelicci P G, Allavena P, Subar M, et al. T cell receptor (α, β, γ) gene rearrangements and expression in normal and leukemic large granular lymphocytes/natural killer cells. Blood 1987; 70(5)1500–1508
   PubMed Web of Science ®Google Scholar
• Wood G S, Abel E A, Hoppe R T, et al. Leu-8 and Leu-9 antigen phenotypes: Immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation. J Am Acad Dermatol 1986; 14: 1006–1013
   PubMed Web of Science ®Google Scholar
• Ralfkiaer E, O'Connor N TJ, Crick J, et al. Genotypic analysis of cutaneous T cell lymphomas. J Invest Dermatol 1987; 88: 762–765
   PubMed Web of Science ®Google Scholar
• Abel E A, Wood G S, Hoppe R T, et al. Expression of Leu-8 antigen, a majority T cell marker, is uncommon in mycosis fungoides. J Invest Dermatol 1985; 85: 199–202
   PubMed Web of Science ®Google Scholar
• Ralfkiaer E, Wantzin G L, Mason D Y, et al. Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Am J Clin Pathol 1985; 84: 610–619
   PubMed Web of Science ®Google Scholar
• Winberg C D. Peripheral T cell lymphoma: Morphologic and immunologic observations. Hum Pathol 1993; 99(4)426–435
   Google Scholar
• Pinkus G S, O'Hara C J, Said J W. Peripheral/post-thymic T cell lymphomas: A spectrum of disease—Clinical, pathologic, and immunologic features of 78 cases. Cancer 1990; 65: 971–998
   PubMed Web of Science ®Google Scholar
• Weiss L M, Crabtree G S, Rouse R V, et al. Morphologic and immunologic characterization of 50 peripheral T cell lymphomas. Am J Pathol 1985; 118: 316–324
   PubMed Web of Science ®Google Scholar
• Grogan T M, Fielder K, Rangel C, et al. Peripheral T cell lymphoma: Aggressive disease with heterogeneous immunotypes. Am J Clin Pathol 1985; 83: 279–288
   PubMed Web of Science ®Google Scholar
• Borowitz M J, Reichert T A, Brynes R K, et al. The phenotypic diversity of peripheral T cell lymphomas: The Southeastern Cancer Study Group experience. Hum Pathol 1986; 17: 567–574
   PubMed Web of Science ®Google Scholar
• Weis J W, Winter M W, Phyliky R L, et al. Peripheral T cell lymphomas: Histologic, immunohistologic, and clinical characterization. Mayo Clin Proc 1986; 61: 411–426
   PubMed Web of Science ®Google Scholar
• Strickler J G, Weiss L M, Copenhaver C M, et al. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T cell lymphomas. Hum Pathol 1987; 18: 808–814
   PubMed Web of Science ®Google Scholar
• Weiss L M, Picker L J, Grogan T M, et al. Absence of clonal beta and gamma T cell receptor gene rearrangements in a subset of peripheral T cell lymphomas. Am J Pathol 1988; 130: 436–442
   PubMed Web of Science ®Google Scholar
• Weiss L M, Strickler J G, Dorfman R F, et al. Clonal T cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol 1986; 122: 392–397
   PubMed Web of Science ®Google Scholar
• Lipford E H, Margolick J B, Longo D L, et al. Angiocentric immunoproliferative lesions: A clinicopathologic spectrum of post-thymic T cell proliferations. Blood 1988; 72(5)1674–1681
   PubMed Web of Science ®Google Scholar
• Spencer J, Cerf-Bensussan N, Jarry A, et al. Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol 1988; 132: 1–5
   PubMed Web of Science ®Google Scholar
• Spencer J, MacDonald T T, Diss T C, et al. Changes in intraepithelial lymphocyte subpopulations in coeliac disease and enteropathy associated T cell lymphoma (malignant histiocytosis of the intestine). Gut 1989; 30: 339–346
   PubMed Web of Science ®Google Scholar
• Wolf B C, Martin A W, Ree H J, et al. Non-Hodgkin's lymphomas of the gastrointestinal tract: An evaluation of paraffin section immunostaining. Am J Clin Pathol 1990; 93: 233–239
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Clark J, Steis R. Lymph node pathology of HTLV and HTLV-associated neoplasms. Cancer Res 1985; 45(Suppl)4662s–4664s
   PubMedGoogle Scholar
• Chadburn A, Athan E, Wieczorek R, et al. Detection and characterization of human T cell lymphotropic virus type I (HTLV-I) associated T cell neoplasms in an HTLV-I nonendemic region by polymerase chain reaction. Blood 1991; 77(11)2419–2430
   PubMed Web of Science ®Google Scholar
• Chan K C. CD30+ (Ki-1) lymphoma: t(2;5) translocation, the implicated genes, and more. Adv Anat Pathol 1995; 2(2)99–104
   Google Scholar
• Morris S W, Kirstein M N, Valentine M B, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281–1284, (Commentary)
   PubMed Web of Science ®Google Scholar
• Kinney M C, Collins R D, Greer J P, et al. A small cell predominant variant of primary Ki-1 (CD30)+ T cell lymphoma. Am J Surg Pathol 1993; 17(9)859–868
   PubMed Web of Science ®Google Scholar
• Kinney M C, Glick A D, Stein H, et al. Comparison of anaplastic large cell Ki-1 lymphomas and microvillous lymphomas in their immunologic and ultrastructural features. Am J Surg Pathol 1990; 14(11)1047–1060
   PubMed Web of Science ®Google Scholar
• Agnarsson B A, Kadin M E. Ki-1 positive large cell lymphoma—A morphologic and immunologic study of 19 cases. Am J Surg Pathol 1988; 12(4)264–274
   PubMed Web of Science ®Google Scholar
• Rimokh R, Magaud J P, Berger F, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (Ki-1 lymphoma). Br J Hematol 1989; 71: 31–36
   PubMed Web of Science ®Google Scholar
• Herbst H, Tippelmann G, Anagnoslopoulos I, et al. Immunoglobulin and T cell receptor gene rearrangements in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma: Dissociation between phenotype and genotype. Leuk Res 1989; 13(2)103–116
   PubMed Web of Science ®Google Scholar
• Fischer P, Nacheva E, Mason D Y, et al. A Ki-1 (CD30) positive human cell line (Karpas 299) established from a high grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T cell receptor β-chain gene. Blood 1988; 72(1)234–240
   PubMed Web of Science ®Google Scholar